Acetylsalicylic acid ASA

DRUG2 trials

Sponsors

AstraZeneca, Universitätsklinikum Hamburg-Eppendorf

Conditions

ACS (Acute Coronary Syndrome)Acute Coronary SyndromePercutaneous Coronary InterventionSCAD

Phase 3

Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

CompletedNCT01294462

AstraZenecaAcute Coronary Syndrome, Percutaneous Coronary Intervention

Start: 2011-02-28End: 2012-07-31Updated: 2014-06-27

Phase 4

Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial

Not yet recruitingNCT07683923

Universitätsklinikum Hamburg-EppendorfACS (Acute Coronary Syndrome), SCAD

Start: 2027-03-01End: 2033-02-28Target: 3518Updated: 2026-07-06

Related Papers

Ticagrelor: analysis of clinical trial registries

Figshare2014-01-01